AdvertisementJohnson & Johnson, Eli Lilly Pause COVID-19 Drug TrialsOctober 13, 2020Laurel WamsleyVanessa RomofacebookEmailThe phase 3 trial of Johnson & Johnson's COVID-19 vaccine candidate has been paused as the company investigates what it says is a study participant's "unexplained illness." (AP)